The results provide support for the measurement properties of the Rasch-scaled 28-item version of the IVI and of its potential for assessing outcomes of low-vision rehabilitation. A raw score-to-Rasch person measure conversion is supplied.
Aims: To describe the impact of age related macular degeneration (AMD) on quality of life and explore the association with vision, health, and demographic variables. Methods: Adult participants diagnosed with AMD and with impaired vision (visual acuity ,6/12) were assessed with the Impact of Vision Impairment (IVI) questionnaire. Participants rated the extent that vision restricted participation in activities affecting quality of life and completed the Short Form General Health Survey (SF-12) and a sociodemographic questionnaire. Results: The mean age of the 106 participants (66% female) was 83.6 years (range 64-98). One quarter had mild vision impairment, (VA,6/12-6/18) and 75% had moderate or severely impaired vision. Participants reported from at least ''a little'' concern on 23 of the 32 IVI items including reading, emotional health, mobility, and participation in relevant activities. Those with mild and moderate vision impairment were similarly affected but significantly different from those with severe vision loss (p,0.05). Distance vision was associated with IVI scores but not age, sex, or duration of vision loss. Conclusion: AMD affects many quality of life related activities and not just those related to reading. Referral to low vision care services should be considered for people with mild vision loss and worse.A ge related macular degeneration (AMD) is a leading cause of vision impairment in the developed world.1 Success of treatment is often defined in terms of preservation of remaining vision rather than improvement in vision.2 There are few known risk factors and evidence for the prevention of AMD remains intangible.3 While intensive research continues into new treatments, potential new environmental and genetic risk factors, and predictive and preventative measures, 2 3 there has been less focus on the impact of vision impairment on people with AMD. Clinicians and the community in general undervalue or are not well aware of the broad impact of AMD on health related quality of life. 4 We know vision loss is associated with increased morbidity, including an increased risk of falls. 5 6 Recent research has shown how vision impairment compromises quality of life and limits social interaction and independence.6 7 Vision impairment caused by AMD has also been shown to interfere with the person's ability to care for themselves and others indicating need for community and vision related support. 8Vision loss from AMD has been shown to be associated with depression and that significant psychological distress is similar to that of people with other serious chronic illness. 9 10 Therefore, the current lack of effective preventive measures and treatment for most people with AMD emphasises the importance of timely referral and vision rehabilitation, yet only a small proportion of people with impaired vision access low vision rehabilitation services. [11][12][13] Consequently, the aim of this paper was to describe the impact of vision loss from AMD on a broad range of daily life activities and to determine the ...
Significant improvements in overall quality of life and two specific areas of daily living in people with low vision were found, although the magnitude and clinical significance of the rehabilitation-induced gains were modest. Further investigation in other models of low-vision rehabilitation is needed to optimize quality of life gains in people with low vision.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.